-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Downgrades Lisata Therapeutics to Neutral

Benzinga·05/15/2026 15:50:04
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis downgrades Lisata Therapeutics (NASDAQ:LSTA) from Buy to Neutral.